Form D · Other
Arena Therapeutics OpCo, Inc.
Edina, MN · CIK 0002028972
Offering snapshot reported Jul 1, 2024 · SEC filing
- Reported sold
- $600K Offering amount: $2M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 4, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 1, 2024 | Initial | $600,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-517484
Source: Form D, filed Jul 1, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David Charles | Director |
| Tim De Lapp | Director |
| Mallory Hacker | Director |
| Brian Kennedy | Director, Executive |
| Todd Langevin | Director |
Issuer details
Industry: Other (See others in industry)
Address:
5504 Brookview Ave
Edina, MN, 55424
Edina, MN, 55424